This study demonstrates that chronic microglial activation, driven by damage-associated molecular patterns (DAMPs) such as Aβ and hyperphosphorylated tau, induces the release of pro-inflammatory cytokines, such as TNF-α and IL-1β, which exacerbate neuroinflammation and drive the progression of AD. The gene discussed is MAPT; the disease is Alzheimer disease.